AQP1 and Stroke: We conclude that the water channel AQP1 is a suitable target for the control of thrombotic events and, that when available, clinically safe and effective AQP1 inhibitors may represent a novel class of antiprocoagulant antithrombotics for the management of arterial thrombotic disease, including acute coronary syndrome, coronary artery disease, and stroke.